Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

White Blood Cells Gene Expression Profiles as a Tool for Predicting Metformin Efficacy in Patients With Type 2 Diabetes Mellitus

NCT01334684 is registered in ClinicalTrials.gov with Casa Sollievo della Sofferenza IRCCS as lead sponsor.

NCT NCT01334684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01334684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
White Blood Cells Gene Expression Profiles as a Tool for Predicting Metformin Efficacy in Patients With Type 2 Diabetes Mellitus
Lead sponsor
Casa Sollievo della Sofferenza IRCCS
Phase
Not applicable
Overall status
Unknown status
Start date
May 31, 2011
Completion date
September 30, 2013
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes